Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2003
08/14/2003US20030152614 Enhanced drug delivery in transdermal systems
08/14/2003US20030152613 Steroid on carrier containing pressure sensitive adhesive
08/14/2003US20030152600 Novel compounds of the n-acylamino-amide-family, cpmpositions comprising same, and uses
08/14/2003US20030152595 Storage stability
08/14/2003US20030152587 Immunomoderators; high molecular weight polysaccharides
08/14/2003US20030152582 CTL epitopes from EBV
08/14/2003US20030152575 Using antiidiotypeic antibodies; anticancer, antitumor antibodies
08/14/2003US20030152572 Blocking production of synoviocytes; antiinflammatory agents; prevent signal transduction
08/14/2003US20030152571 Anti-alphabeta3 humanized monoclonal antibodies
08/14/2003US20030152558 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
08/14/2003US20030152536 Cosmetic preparations containing waltheria indica extracts
08/14/2003US20030152514 Methods for using anti-MUC18 antibodies
08/14/2003CA2776902A1 Salts of valsartan
08/14/2003CA2737565A1 N-phenyl-2-pyrimidine-amine derivatives
08/14/2003CA2486446A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
08/14/2003CA2483630A1 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations
08/14/2003CA2478423A1 Gamma secretase inhibitors
08/14/2003CA2476281A1 Pyrimidine compounds
08/14/2003CA2476275A1 Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate cns nerve regeneration
08/14/2003CA2476218A1 Therapeutic compounds
08/14/2003CA2476214A1 Proliferated cell lines and uses thereof
08/14/2003CA2475767A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003CA2475385A1 Hair growth promoting agent, percutaneously applied preparation, and hair growth promoting method
08/14/2003CA2475377A1 Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
08/14/2003CA2475329A1 Truncated aggrecanase molecules
08/14/2003CA2475112A1 Anti-infarction molecules
08/14/2003CA2475108A1 Treating benign prostate hyperplasia with sarms
08/14/2003CA2474974A1 Cytoprotective benzofuran derivatives
08/14/2003CA2474921A1 Pharmaceutical tablet
08/14/2003CA2474888A1 Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan
08/14/2003CA2474884A1 Stimulation of cpt-1 as a means to reduce weight
08/14/2003CA2474783A1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
08/14/2003CA2474778A1 A novel target to inhibit angiogenesis
08/14/2003CA2474748A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003CA2474424A1 Salts of valsartan
08/14/2003CA2474398A1 New immunoeffector compounds
08/14/2003CA2474214A1 Novel aryl- and heteroarylpiperazines
08/14/2003CA2474203A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization, or both, in humans
08/14/2003CA2474168A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003CA2474016A1 A combination for treating cold and cough
08/14/2003CA2473802A1 Engineering absorption of therapeutic compounds via colonic transporters
08/14/2003CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003CA2473706A1 Heterocyclic compounds having elastase-inhibitory activity and intermediates thereof
08/14/2003CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003CA2473459A1 Pyridineamido derivatives as inhibitors of monoamine oxidase (mao-b)
08/14/2003CA2473212A1 Pharmaceutical composition which improves in vivo gene transfer
08/14/2003CA2473182A1 Compositions and methods for treatment of vitamin d deficiency
08/14/2003CA2473181A1 Quinoline derivatives as npy antagonists
08/14/2003CA2471586A1 Tumor necrosis factor combined with interferon in demyelinating diseases
08/14/2003CA2471207A1 Method of inhibiting pathogenicity of infectious agents
08/14/2003CA2469748A1 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
08/14/2003CA2467555A1 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl)-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-me thyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
08/14/2003CA2466294A1 Hexa-, hepta-, and octapeptides having antiangiogenic activity
08/14/2003CA2450807A1 Non-myeloablative tolerogenic treatment with tyrphostins
08/13/2003EP1335202A1 Method for screening compounds being modulators of neuromediators
08/13/2003EP1335018A1 Sericin-containing material, process for producing the same and method of using the same
08/13/2003EP1334725A2 Estroprogestative contraceptive composition
08/13/2003EP1334717A2 Pharmaceutical Compositions For Oral And Topical Administration
08/13/2003EP1334358A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334193A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/13/2003EP1334192A2 Cystoskeleton-associated proteins
08/13/2003EP1334178A1 Slo2 and slo4, novel potassium channel proteins from human brain
08/13/2003EP1334126A1 Human stra6-like protein and nucleic acids encoding the same
08/13/2003EP1334118A2 Methods and reagents for regulation of cellular responses in biological systems
08/13/2003EP1334106A2 Novel imidazole derivatives, production method thereof and use thereof
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334089A1 Quinoline derivatives as nk-3 and nk-2 antagonists
08/13/2003EP1334088A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
08/13/2003EP1334087A1 Cycloalkylfluorosulfonamide derivatives
08/13/2003EP1334085A1 Sulfamides as gamma-secretase inhibitors
08/13/2003EP1333856A1 Modulating angiogenesis
08/13/2003EP1333855A1 Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders
08/13/2003EP1333853A1 Growth factor complex
08/13/2003EP1333845A1 Treatment of t cell disorders
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333839A1 Method for the treatment of inflammation
08/13/2003EP1333838A2 Compounds comprising a phytosterol and/or phytostanol moiety and ascorbic acid and use thereof as weight regulating agents
08/13/2003EP1333837A1 Improved treatment
08/13/2003EP1333834A2 Antiinflammation agents
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333831A2 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
08/13/2003EP1333830A2 Novel medicament compositions based on anticholinergics and corticosteroids
08/13/2003EP1333829A1 Treatment of sexual dysfunction using bombesin antagonists
08/13/2003EP1333824A2 Treatment of sexual dysfunction
08/13/2003EP1333823A1 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
08/13/2003EP1333822A2 Treatment of diseases with adamantane derivatives
08/13/2003EP1333821A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
08/13/2003EP1333810A2 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1220845B1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
08/13/2003EP1181025B1 Molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy
08/13/2003EP1165540B1 Tetrahydropyran derivatives and their use as therapeutic agents
08/13/2003EP1143981A4 Treatment and prevention of hiv and other viral infections
08/13/2003EP1140943B1 Substituted pyrroloindoles
1 ... 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 ... 1564